Latest filing published 14 Feb 2023 for Rhythm Pharmaceuticals, INC., €31k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Jennifer Chien: trading record in brief
Jennifer Chien, listed as chief executive, appears in our data through filings on Rhythm Pharmaceuticals, Inc. shares, published by SEC (Form 4). We count 7 filings; the first trade dates from 11 February 2022 and the latest from 14 February 2023.
Every open-market trade on record is a sale: 4 sales worth €81k. Besides market trades, the filings include 3 option exercises. 2023 to date brings no purchases and 3 sales.
The newest entry dates from 14 February 2023: an open-market sale of €16k, in Rhythm Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jennifer Chien
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,204 shares@ US$27.51100.0% of flowCommon StockSEC:0001104659-23-022065:0
- 2,031 sharesCommon StockSEC:0001104659-23-022113:0
- 3,438 sharesCommon StockSEC:0001104659-23-019835:0
- 2,032 sharesCommon StockSEC:0001104659-22-023948:0
4 of 4 declarations
